Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors

Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors

US Patent 11613548 · Granted Mar 28, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as pad inhibitors2025
Cerdulatinib for the treatment of b-cell malignancies2025
Compositions for management of polycystic ovary syndrome2025
Dichlorophenol HSD17B13 inhibitors and uses thereof2025
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inh2024
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024